{"id":476420,"date":"2020-03-26T13:42:02","date_gmt":"2020-03-26T13:42:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=476420"},"modified":"2020-03-26T13:42:02","modified_gmt":"2020-03-26T13:42:02","slug":"bipolar-disorder-epidemiology-analysis-and-forecast-3year-historical-and-11year-forecasted-analysis","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/bipolar-disorder-epidemiology-analysis-and-forecast-3year-historical-and-11year-forecasted-analysis_476420.html","title":{"rendered":"Bipolar Disorder Epidemiology Analysis and Forecast: 3-year historical and 11-year Forecasted analysis"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1585225604.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Bipolar Disorder Epidemiology Analysis and Forecast: 3-year historical and 11-year Forecasted analysis\" src=\"https:\/\/www.abnewswire.com\/uploads\/1585225604.jpeg\" alt=\"Bipolar Disorder Epidemiology Analysis and Forecast: 3-year historical and 11-year Forecasted analysis\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Bipolar Disorder Epidemiology Analysis<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight&#8217;s &#8220;Bipolar Disorder Epidemiology Report&#8221; delivers an in-depth understanding of the   Bipolar Disorder- with 3-year historical analysis of the patient pool \u2013 diagnosed \u2013 incident and prevalent and 11-year Bipolar disorder forecast analysis with the shift in trends in the 7MM during 2017-30.  <\/div>\n<p style=\"text-align: justify;\"><strong>Bipolar disorder: Disease understanding<\/strong><\/p>\n<p style=\"text-align: justify;\">Bipolar Disorder (Manic depression) is categorized by recurrent-shifts in the mood\/temper and is a manic-depressive disorder hindering the routine life of an individual.<\/p>\n<p style=\"text-align: justify;\">The American Psychiatric Association categorizes Bipolar disorder into four major types of bipolar disorder: Bipolar I disorder, Bipolar II disorder, Cyclothymic disorder, and Bipolar disorder due to another medical or substance abuse disorder.<\/p>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s &lsquo;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/bipolar-disorder-manic-depression-epidemiology-forecast\">Bipolar Disorder (Manic Depression) &#8211; Epidemiology Forecast to 2030&rsquo;<\/a> report proofers an exhaustive coverage of the disease, listing down aetiology, pathophysiology, symptoms, origins of the diseases, and prevailing epidemiological and treatment trends.<\/p>\n<p style=\"text-align: justify;\"><strong>Bipolar disorder is the most impairing among mental disorders. &nbsp;<\/strong>Bipolar disorder affects about 45 million people worldwide, says WHO.<\/p>\n<p style=\"text-align: justify;\"><strong>Bipolar disorder Epidemiology:<\/strong> <strong>3-year historical and 11-year forecasted analysis <\/strong><\/p>\n<p style=\"text-align: justify;\">The condition affects men and women equally. &nbsp;Bipolar disorder afflicts around 5.7 million adult n the US, or about 2.6% of the American population age 18 and older every year.<\/p>\n<p style=\"text-align: justify;\">The Bipolar disorder epidemiology report outlays a focused view on historical and forecasted Bipolar disorder epidemiology, presenting total cases, diagnosed pool, prevalence and incidence of the condition in the <strong>7MM (<\/strong>the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan) for the <strong>Study Period &ndash; 2017-30. <\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/bipolar-disorder-manic-depression-epidemiology-forecast\">Know more about the report.<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Bipolar Disorder (Manic Depression) Detailed Epidemiology Segmentation<\/strong><\/p>\n<p style=\"text-align: justify;\">The Bipolar Disorder (Manic Depression) epidemiology report provides segmented analysis into geography, types, and other parameters.<\/p>\n<p style=\"text-align: justify;\">The report provides 3-year historical as well as 11-year forecasted Bipolar Disorder (Manic Depression) epidemiology scenario in <strong>the 7MM<\/strong> covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan for the <strong>Study period: 2017 to 2030.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/blog\/bipolar-disorder-market\/\">Read more.<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Report Highlights <\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>11-Year Forecast of Bipolar disorder epidemiology<\/li>\n<li>7MM Coverage<\/li>\n<li>Bipolar disorder total cases<\/li>\n<li>Bipolar disorder cases according to segmentation<\/li>\n<li>Bipolar disorder Diagnosed cases<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/bipolar-disorder-manic-depression-epidemiology-forecast\">Request for Sample Pages<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents <\/strong><\/p>\n<p style=\"text-align: justify;\">1. Key Insights<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary of Bipolar disorder<\/p>\n<p style=\"text-align: justify;\">3. Bipolar disorder: Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">4.&nbsp;Patient Journey<\/p>\n<p style=\"text-align: justify;\">5.&nbsp;Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">6.&nbsp;Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n<p style=\"text-align: justify;\">7.&nbsp;KOL Views<\/p>\n<p style=\"text-align: justify;\">8.&nbsp;Unmet Needs<\/p>\n<p style=\"text-align: justify;\">9.&nbsp;&nbsp;Appendix<\/p>\n<p style=\"text-align: justify;\">10.&nbsp;DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">11.&nbsp;Disclaimer<\/p>\n<p style=\"text-align: justify;\"><em>*The table of contents is not exhaustive; will be provided in the final report<\/em><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About DelveInsight <\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for<\/p>\n<p style=\"text-align: justify;\">Browse through our vast repository from <a rel=\"nofollow\" href=\"https:\/\/delveinsight.com\/report-store.php\">here<\/a>.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_55879.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Ankit Nigam<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=bipolar-disorder-epidemiology-analysis-and-forecast-3year-historical-and-11year-forecasted-analysis\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +919650213330<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=bipolar-disorder-epidemiology-analysis-and-forecast-3year-historical-and-11year-forecasted-analysis\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bipolar Disorder Epidemiology Analysis DelveInsight&#8217;s &#8220;Bipolar Disorder Epidemiology Report&#8221; delivers an in-depth understanding of the Bipolar Disorder- with 3-year historical analysis of the patient pool \u2013 diagnosed \u2013 incident and prevalent and 11-year Bipolar disorder forecast analysis with the shift &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/bipolar-disorder-epidemiology-analysis-and-forecast-3year-historical-and-11year-forecasted-analysis_476420.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[435,405,406,420,404],"tags":[],"class_list":["post-476420","post","type-post","status-publish","format-standard","hentry","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Science","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/476420","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=476420"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/476420\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=476420"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=476420"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=476420"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}